BATS BZX Real-Time Price
As of 10:33am ET
| +0.22 / +1.59%|
The 10 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 11.00, with a high estimate of 20.00 and a low estimate of 5.25. The median estimate represents a -21.54% decrease from the last price of 14.02.
The current consensus among 11 polled investment analysts is to Hold stock in ImmunoGen Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.